课题基金 / 基金详情

PROTEIN DENATURATION--ITS ROLE IN HYPERTHERMIC BIOLOGY

PROTEIN DENATURATION--ITS ROLE IN HYPERTHERMIC BIOLOGY
蛋白质变性——它在高温生物学中的作用
批准号:
2330843
负责人:
Michael Jude Borrelli
金额:
$16.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-02-01 至 1999-01-31

项目摘要

项目成果

Michael Jude Borrelli的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The working hypothesis of the proposed study is that heat-denatured proteins represent the rudimentary hyperthermic lesion that causes cell killing and induces thermotolerance. Denatured proteins initiate the formation of protein aggregates which subsequently disrupt normal cellular structure and function. Ultimately denaturation aggregation related damage prevents cell from undergoing a successful mitosis and they are rendered clonogenically dead. Thermotolerance is induced by the presence of denatured and/or aggregated proteins and protects cells from hyperthermic killing by inhibiting protein denaturation-aggregation and facilitating the disaggregation process. The experiments are designed to demonstrate unequivocally that protein denaturation-aggregation is a lethal hyperthermic lesion and to determine how it causes cell death. The cytotoxicity of denatured proteins in the absence of other hyperthermic damage will be determined by electroporating heat-denatured proteins into nonheated cells and quantitating the resultant cytotoxicity. Complementary experiments will involve electroporating mammalian cells with thermolabile, nonmammilian proteins. The ability of the thermolabile proteins to either sensitize cells to heat or lower the threshold temperature for cell killing will support protein denaturation as a lethal hyperthermic lesion. Experiments will then be performed to confirm protein aggregation as a direct consequence of protein denaturation and to determine if the magnitude of protein aggregation, integrated over both the heating time and post heating recovery serves as a measurement of the cytotoxic dose. Efforts will then be directed towards identifying specific cellular targets that express lethal hyperthermic damage. Experimental approaches will include cell enucleation and refusion techniques to determine the cytotoxity associated heating the cytoplasm nor nucleus. We will determine if aggregated proteins interfere with normal nuclear function in a manner that results in micronuclei or aberrant chromosomes. Heat damage to the centrosome will also be investigated for its effect on cell viability. Finally, we will determine the mechanisms by which thermotolerance protects cells against protein denaturation/aggregation. This will include experiments to determine the relative efficacy of the major heat shock proteins in inhibiting aggregate formation and facilitating the disaggregation process. The results of this study will provide fundamental knowledge concerning the interactions of hyperthermia with biological cells which can be used in the development of hyperthermia as a clinical modality for treating human cancers. Protein denaturation/aggregation has also been implicated as a lethal lesion in other stresses of clinical import, e.g., ischemia. Thermotolerance protects against these other stresses which themselves induce thermotolerance. This cross-resistance provided by thermotolerance suggest that is part of a more generalized mechanism that has evolved to protect cells from stress. Thus, the information obtained from this study may have broader medical implications than the narrow application of hyperthermic oncology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Seventh Nanotechnology for Health Care Conference
  • 批准号:
    9805451
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2018
  • 负责人:
    Michael Jude Borrelli
  • 依托单位:
The Fifth Nanotechnology for Health Care Conference
  • 批准号:
    9094250
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2014
  • 负责人:
    Michael Jude Borrelli
  • 依托单位:
The Fifth Nanotechnology for Health Care Conference
  • 批准号:
    8849339
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2014
  • 负责人:
    Michael Jude Borrelli
  • 依托单位:
The Fifth Nanotechnology for Health Care Conference
  • 批准号:
    8792651
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2014
  • 负责人:
    Michael Jude Borrelli
  • 依托单位:
国内基金
海外基金
靶向DNA聚合酶α的海洋来源新型aphidicolin类二萜结构多样性挖掘及其抗肿瘤作用机制研究
深海真菌中aphidicolin衍生物的靶向发现
  • 批准号:
    41906104
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    27.0万元
  • 批准年份:
    2019
  • 负责人:
    夏金梅
  • 依托单位:
DNA聚合酶抑制剂(+)-Aphidicolin全合成研究
  • 批准号:
    21062024
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    27.0万元
  • 批准年份:
    2010
  • 负责人:
    赵元鸿
  • 依托单位: